These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 21114983

  • 1. Megestrol acetate inhibits the expression of cytoplasmic aromatase through nuclear C/EBPβ in reperfusion injury-induced ischemic rat hippocampus.
    Kelicen Ugur P, Lule S, Cincioglu M, Pekiner C, Gursoy-Ozdemir Y.
    Eur J Pharmacol; 2011 Mar 11; 654(3):217-25. PubMed ID: 21114983
    [Abstract] [Full Text] [Related]

  • 2. Indinavir inhibits the expression of cytoplasmic aromatase and nuclear SREBP in the hippocampus of reperfusion injury-induced ischemic rats.
    Cincioglu M, Kismali G, Ugur SA, Kelicen-Ugur P.
    J Steroid Biochem Mol Biol; 2012 May 11; 130(1-2):81-9. PubMed ID: 22342839
    [Abstract] [Full Text] [Related]

  • 3. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J, Gurates B, Yang S, Sebastian S, Bulun SE.
    Cancer Res; 2001 Mar 01; 61(5):2328-34. PubMed ID: 11280806
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia.
    Ejarque-Ortiz A, Medina MG, Tusell JM, Pérez-González AP, Serratosa J, Saura J.
    Glia; 2007 Jan 15; 55(2):178-88. PubMed ID: 17078024
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early c-Fos induction after cerebral ischemia: a possible neuroprotective role.
    Cho S, Park EM, Kim Y, Liu N, Gal J, Volpe BT, Joh TH.
    J Cereb Blood Flow Metab; 2001 May 15; 21(5):550-6. PubMed ID: 11333365
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion.
    Zhang WW, Zhang L, Hou WK, Xu YX, Xu H, Lou FC, Zhang Y, Wang Q.
    Chin Med J (Engl); 2009 Sep 05; 122(17):1996-2001. PubMed ID: 19781384
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
    Cho IJ, Ki SH, Brooks C, Kim SG.
    Xenobiotica; 2009 Feb 05; 39(2):182-92. PubMed ID: 19255944
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Molecular mechanism of inhibition of sodium butyrate on activation of tumor associated aromatase promoters].
    Zhou JF, Liu WL, Chen G, Lu YP, Ma D.
    Ai Zheng; 2002 Dec 05; 21(12):1283-7. PubMed ID: 12520731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Altered expression of the neuropeptide-processing enzyme carboxypeptidase E in the rat brain after global ischemia.
    Jin K, Graham SH, Nagayama T, Goldsmith PC, Greenberg DA, Zhou A, Simon RP.
    J Cereb Blood Flow Metab; 2001 Dec 05; 21(12):1422-9. PubMed ID: 11740203
    [Abstract] [Full Text] [Related]

  • 20. Activation of extracellular signal-regulated kinase 5 may play a neuroprotective role in hippocampal CA3/DG region after cerebral ischemia.
    Wang RM, Zhang QG, Li CH, Zhang GY.
    J Neurosci Res; 2005 May 01; 80(3):391-9. PubMed ID: 15789369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.